15 years ago

Domainex Secures Funding for Cancer Drug Discovery Advancements

  • Domainex, a UK-based drug discovery company focused on cancer therapies, has secured funding to advance its novel drug targets

  • This investment will enable the company to pursue corporate collaborations and deals, further developing its potential solutions for cancer treatment.

      • ProblemHealthcare

      "Drug discovery is a slow and expensive process, with many potential drugs failing in clinical trials. This leads to high costs for pharmaceutical companies and delays in getting new drugs to patients."

      Solution

      "Domainex is a drug discovery company that uses a novel approach to identify and develop new drugs. They focus on novel targets for cancer and aim to bring their discoveries to the market faster and at lower costs than traditional methods."

      Covered on